Montefiore continues to occupy a position in the top tier of U.S. News and World Report’s Best Hospital rankings for 2017–2018. This annual look at hospitals across the country provides valuable information for healthcare consumers seeking the best care.

Placing again in the top 1% for specialty care in Diabetes & Endocrinology, Montefiore also continues to rank among the top 10% in Cancer, Gastroenterology, Geriatrics, Nephrology, Neurology, Pulmonology, Urology, Coronary Artery Bypass Grafting (CABG), heart failure (CHF), Colon Cancer Surgery, and Chronic Obstructive Pulmonary Disease (COPD).

In addition to Montefiore’s strong performance on the national level, we rank in the top 10 both in the State of New York and the New York Metro area. This is a notable achievement in a region of the country with an extraordinary concentration of high performing medical institutions.

Montefiore and our Einstein College of Medicine embrace the principle of doing more for every patient in every community we serve. Discovering new lifesaving treatments, deploying the latest technologies and delivering the coordinated, compassionate care every patient deserves keeps Montefiore in the top tier of the nation’s hospitals.

Montefiore Pediatric Diabetes and Endocrinology Nurse Practitioners Amy Dowd, CPNP, Rebecca Crespi, CPNP, and Leigh Pughe, CPNP, with Z100’s Garrett Vogel.

Diabetes is no walk in the park for a child, but thanks to Children’s Hospital at Montefiore (CHAM) it can be a trip to the zoo. CHAM’s Division of Pediatric Endocrinology and Diabetes hosted their 6th Annual Family Diabetes Day at the Bronx Zoo on July 25, for about 200 patients and family members. Fun and inspiration were on tap with Z100 D.J. Garrett Vogel discussing his own experiences with type 1 diabetes. Other speakers included an attorney who shared information about education rights; a counselor from Camp Nejeda, New Jersey, a destination for kids with type 1 diabetes; Bronx Assemblyman Mark Gjonaj and a current patient. Families checked out the latest insulin pumps and related technologies at vendor displays, and connected with one another as they learned about new treatments. The kids participated in crafts and face painting, and enjoyed their tour of the zoo.

As Alvin Fisher’s health declined, he was not moving up the liver transplant list quickly enough. His Montefiore doctors knew they needed to find a new approach that would increase his odds of getting a donor liver faster. One possibility was to use a liver that otherwise would be discarded because of hepatitis-C infection in the organ. At the same time, new breakthrough treatments for hep-C have a greater than 95% cure rate. Putting this all together, Fisher’s doctors proposed this innovative solution for him. It was Fisher’s trust in his Montefiore doctors that led to his decision to go ahead with the groundbreaking option, to accept a potentially serious illness along with the organ that could save his life.

From left: Samuel Sigal, MD, Sarah Bellemare, MD, patient Alvin Fisher, and Milan Kinkhabwala, MD, Chief, Transplantation. Photo credit: ©Buck Ennis/Crain’s New York Business

In March, Fisher became the first patient in New York without hepatitis-C to receive a donor liver infected with hep-C. Sarah Bellemare, MD, Transplant Surgeon, and Assistant Professor of Surgery, headed the team that performed Fisher’s successful surgery. Since then, two other Montefiore patients have received hep-C donor organs. Fisher has completed one round of treatment for hep-C and is clear of the virus. Two other New York hospitals have followed Montefiore’s lead and several others are working out how to offer this option to their patients. In the meantime, Alvin Fisher has his life back and plans to return to college in the fall.

Read the whole story in Crain’s New York Business: https://goo.gl/771pcJ